Medical Imaging Workstations Market Size, Share, Trends, and Forecast Analysis - Global Forecast to 2036 | AI, Cloud, and Enterprise Imaging Drive 7.3% CAGR and USD 12.55 Billion Opportunity

The global medical imaging workstations market is estimated at USD 6.20 billion in 2026 and projected to reach USD 12.55 billion by 2036, expanding at a CAGR of 7.3%. Growth is driven by rising chronic disease prevalence, digital imaging infrastructure investments, AI integration, and enterprise imaging adoption. Key challenges include high costs, cybersecurity risks, and radiologist shortages, while opportunities exist in cloud-based solutions and emerging markets.

11/06/2026, 10:59 AM • GlobeNewswire

Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics

Siemens Healthineers has initiated the carve-out process for its in vitro diagnostics business, which will operate as a standalone company under the name Olyrian Diagnostics by mid-2028. Simultaneously, Siemens Healthineers will rebrand to 'Healthineers'. Olyrian will focus on advancing diagnostics across the care continuum with a purpose of 'powering human potential at the heart of care', building on over a century of diagnostic testing legacy.

11/05/2026, 1:00 AM • GlobeNewswire

Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases

Radiopharm Theranostics received FDA alignment on a pivotal Phase 3 trial design for RAD101, a novel imaging agent for detecting brain metastases. The single multicenter trial will enroll approximately 280 patients and is substantially smaller than historical imaging studies, reflecting significant unmet medical need. The company expects to initiate the trial in the first half of 2027 with manufacturing support from Siemens Healthineers.

11/04/2026, 7:00 AM • GlobeNewswire

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics announced successful completion of an End-of-Phase 2 meeting with the FDA for RAD101, a brain metastases imaging agent that demonstrated 93% concordance with MRI. The company is preparing to initiate a pivotal Phase 3 trial in 1Q27 and has secured a manufacturing partnership with Siemens Healthineers. Additionally, Radiopharm reported positive Phase 1 imaging data for RAD301 in pancreatic cancer and advanced RAD202 to the fourth dosing cohort in its HER2+ solid tumor study.

11/02/2026, 8:00 AM • GlobeNewswire

Global Computed Tomography (CT) Market by Application, Technology, Care Setting, and Product: Five-Year Forecast | Photon-Counting Scanners and AI Breathe New Life Into a Mature CT Market

The global computed tomography market is experiencing significant innovation driven by photon-counting technology, AI integration, and mobile imaging systems. Despite market maturity and coverage challenges, these advances are expanding access to CT imaging across hospitals, clinics, and emerging care settings including veterinary and dental applications. Key manufacturers are competing on slice count, AI capabilities, and spectral imaging technologies.

10/23/2026, 10:00 AM • GlobeNewswire

Digital X-ray Market - Global and Regional Analysis and Forecast, 2026-2036 | Mobile Imaging, AI Workflows, and Detector Innovation Drive Growth to $9.90 Billion

The global digital X-ray market is projected to grow from $5.79 billion in 2025 to $9.90 billion by 2036, expanding at a 5.09% CAGR. Growth is driven by the transition from analog to digital systems, adoption of mobile and retrofit solutions, AI-enabled workflows, and detector innovations. North America leads the market, while Asia-Pacific presents significant expansion opportunities. Key challenges include workforce shortages and integration complexity.

10/16/2026, 6:00 AM • GlobeNewswire

Global Mobile X-ray Systems Market Analysis and Forecast, 2026-2036 | AI-Enabled Digital Imaging and Asia-Pacific Growth Drive a $4.00 Billion Market by 2036

The global mobile X-ray systems market is projected to grow from $2.06 billion in 2025 to $4.00 billion by 2036, with a CAGR of 6.30%. Growth is driven by rising chronic disease prevalence, increasing hospitalization rates, and demand for point-of-care imaging. Digital systems dominate with 91.57% market share, while handheld/ultra-portable systems are the fastest-growing segment. Asia-Pacific leads regional growth at 7.43% CAGR, followed by North America and Europe.

10/16/2026, 5:58 AM • GlobeNewswire

Global Mobile C-Arm Market Analysis and Forecast, 2026-2036 | Market to Reach $3.71 Billion as Minimally Invasive Surgery, AI, and 3D Imaging Drive 5.35% CAGR

The global mobile C-arm market is projected to grow from $2.09 billion in 2025 to $3.71 billion by 2036, expanding at a 5.35% CAGR. Growth is driven by rising adoption of minimally invasive surgery, AI integration, 3D imaging, and aging populations. North America leads the market, with hospitals as the primary end-users. Key challenges include high capital costs and shortage of skilled professionals, while advanced storage and archiving capabilities present significant growth opportunities.

10/16/2026, 5:54 AM • GlobeNewswire

Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight

The global liver cancer diagnostics market is projected to grow from USD 10.5 billion in 2025 to USD 19.8 billion by 2034, driven by rising hepatocellular carcinoma incidence, increasing chronic liver disease prevalence, and advances in diagnostic technologies including liquid biopsy, AI-assisted imaging, and blood-based biomarkers. North America leads the market with 41% share, while Asia-Pacific is expected to be the fastest-growing region.

10/01/2026, 1:00 PM • GlobeNewswire

Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032 - AI-Enabled Automation and Integrated Lab Workflows Drive 8.22% CAGR, Lifting the Market to USD 586.85 Million by 2032

The global Therapeutic Drug Monitoring (TDM) consumables market is projected to grow from USD 364.27 million in 2026 to USD 586.85 million by 2032, driven by an 8.22% CAGR. Growth is fueled by AI-enabled automation, integrated lab workflows, standardized collection devices, and improved specimen integrity. Key drivers include workflow integration, digital connectivity, and responsible AI governance across diverse regional markets with distinct operational priorities.

09/28/2026, 4:58 AM • GlobeNewswire

Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight

The global Alzheimer's disease biomarker market is projected to grow from USD 2.2 billion in 2025 to USD 4.7 billion by 2034, driven by rising disease prevalence, aging populations, and advancements in blood-based biomarkers like phosphorylated tau and amyloid-beta assays. North America leads the market with 41% share, while Asia-Pacific is the fastest-growing region. Recent FDA clearances and expanded laboratory testing availability are accelerating market adoption.

09/22/2026, 1:00 PM • GlobeNewswire

Software as a Medical Device Market Set for Rapid Growth Through 2034 as AI Innovation, Digital Health Adoption, and Regulatory Advances Reshape the Competitive Landscape

The global Software as a Medical Device (SaMD) market is projected to grow from USD 2.10 billion in 2025 to USD 8.90 billion by 2034, expanding at a CAGR of 17.4%. Growth is driven by AI-enabled diagnostics, digital therapeutics, cloud-based deployment, and maturing regulatory pathways. Diagnostic and screening software leads with 42% market share, while radiology applications dominate at 34%. North America holds 45% of the market, with Asia-Pacific expected to record the fastest growth.

09/17/2026, 6:51 AM • GlobeNewswire

Ultrasound AI Market Size to Surge to USD 22.03 Billion by 2035 at a CAGR of 26.62% – SNS Insider

The global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.

09/16/2026, 8:30 PM • GlobeNewswire

Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18% - SNS Insider

The Enterprise Imaging Solutions Market is projected to grow from USD 2.32 billion in 2025 to USD 6.69 billion by 2035, with a CAGR of 11.18%. Growth is driven by cloud-native platforms, AI-driven workflows, and vendor consolidation. North America leads with 44% market share, while Asia-Pacific shows the fastest growth at 15% CAGR. Software remains the largest component at 58% share, with cloud deployment and services as the fastest-growing segments.

09/10/2026, 8:30 PM • GlobeNewswire

Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

The global lateral flow assay market is projected to grow from USD 10.84 billion in 2025 to USD 17.66 billion by 2035, with a 5.0% CAGR. Growth is driven by increased adoption of point-of-care testing, technological innovations including CRISPR-based assays, and the shift toward decentralized diagnostic models. Major players include Abbott, Roche, Siemens Healthineers, and Thermo Fisher Scientific, with infectious disease testing accounting for 72.2% of market share.

08/31/2026, 5:04 AM • GlobeNewswire